Because a number of studies demonstrated the anti-colitis activities of PGD2 and its biosynthetic PGD synthases in both experimental colitis and human IBD [16, 46, 59, 60], we propose that the increased PGD2 may suppress colitis in the absence of mPGES-1. This evidence concerns the gene PTGES and inflammatory bowel disease.